3004.90.92.15 - Antineoplastic and immunosuppressive medicaments 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.15, specifically classifies antineoplastic and immunosuppressive medicaments. These are pharmaceutical preparations designed for therapeutic or prophylactic use, administered in measured doses or retail-ready packings. Antineoplastic drugs are used to combat cancer by inhibiting the growth or proliferation of malignant cells, while immunosuppressive medicaments are employed to reduce the activity of the body's immune system, often following organ transplants or to treat autoimmune diseases.
Unlike sibling categories such as anti-infective, cardiovascular, or central nervous system medicaments, this category focuses on drugs that target cellular growth and immune responses rather than specific pathogens, circulatory functions, or neurological pathways. Its distinct purpose lies in modulating the body's own cellular processes or its defense mechanisms for specific, complex medical conditions.
As a leaf node within the HTS structure, this classification does not have further subdivisions. Therefore, the practical application of this code requires careful consideration of the active pharmaceutical ingredients and their intended therapeutic or prophylactic effects. Importers and exporters should ensure that the medicaments are indeed formulated and presented for the treatment of cancer or for suppressing the immune system to align with the specific nature of this classification.